From Childhood to Adulthood: Disease Activity Trajectories in Childhood-Onset Systemic Lupus Erythematosus

被引:17
|
作者
Lim, Lily Siok Hoon [1 ,2 ]
Pullenayegum, Eleanor [3 ]
Feldman, Brian M. [3 ]
Lim, Lillian [3 ]
Gladman, Dafna D. [4 ]
Silverman, Earl D. [3 ]
机构
[1] Univ Manitoba, Winnipeg, MB, Canada
[2] Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[3] Hosp Sick Children SickKids, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
ACTIVITY INDEX 2000; PROLONGED REMISSION; COHORT; DAMAGE; OUTCOMES; SLE; CLASSIFICATION; DETERMINANTS; VALIDATION; FREQUENCY;
D O I
10.1002/acr.23319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. No previous study has studied the longitudinal disease course of childhood-onset systemic lupus erythematosus (cSLE). Our objectives are to assess distinguishable differences in disease activity trajectories in cSLE patients, determine baseline factors predictive of disease trajectory membership, and assess if the different disease activity trajectories are associated with different damage trajectories. Methods. This is a retrospective, longitudinal inception cohort of cSLE patients. Patients were followed from diagnosis as children, until they were adults. SLE disease activity was modeled as a latent characteristic, jointly using the Systemic Lupus Erythematosus Disease Activity Index 2000 and prednisone in a Bayesian growth mixture model. Baseline factors were tested for membership prediction of the latent classes of disease trajectories. Differences in damage trajectories by disease activity classes were tested using a mixed model. Results. A total of 473 patients (82% females), with median age at diagnosis of 14.1 years, were studied. We studied 11,992 visits (2,666 patient-years). We identified 5 classes of disease activity trajectories. Baseline major organ involvement, number of American College of Rheumatology criteria, and age at diagnosis predicted memberships into different classes. A higher proportion of Asians was in class 2 compared to class 5. Class 1 was associated with the most accrual of damage, while class 5 was associated with no significant damage accrual, even after 10 years. Conclusion. There are 5 distinct latent classes of disease trajectory in patients with cSLE. Membership within disease trajectories is predicted by baseline clinical and demographic factors. Membership in different disease activity trajectory classes is associated with different damage trajectories.
引用
收藏
页码:750 / 757
页数:8
相关论文
共 50 条
  • [31] Clinicopathology of childhood-onset renal systemic lupus erythematosus
    Olowu, Wasiu A.
    Adelusola, Kayode A.
    Senbanjo, Idowu
    NEPHROLOGY, 2007, 12 (04) : 364 - 370
  • [32] Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus
    Colin Thorbinson
    Louise Oni
    Eve Smith
    Angela Midgley
    Michael W. Beresford
    Pediatric Drugs, 2016, 18 : 181 - 195
  • [33] Childhood-Onset Systemic Lupus Erythematosus: A Cohort Study
    Ahmed, Shakeel
    Ali, Syed Rehan
    Karim, Farida
    Ishaq, Sidra
    Qaiser, Iman
    Nayani, Kanwal
    Ahmed, Ayesha
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (05): : 365 - 369
  • [34] Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus
    Ana P. Sakamoto
    Clovis A. Silva
    Aline G. Islabão
    Glaucia V. Novak
    Beatriz Molinari
    Paulo K. Nogueira
    Rosa M. R. Pereira
    Claudia Saad-Magalhães
    Gleice Clemente
    Daniela P. Piotto
    Nadia E. Aikawa
    Ana C. Pitta
    Vitor C. Trindade
    Simone Appenzeller
    Luciana M. Carvalho
    Carlos N. Rabelo-Junior
    Adriana R. Fonseca
    Flavio R. Sztajnbok
    Maria C. Santos
    Blanca E. Bica
    Evaldo G. Sena
    Ana J. Moraes
    Melissa M. Fraga
    Teresa C. Robazzi
    Paulo F. Spelling
    Iloite M. Scheibel
    Andre S. Cavalcanti
    Erica N. Matos
    Luciano J. Guimarães
    Flavia P. Santos
    Licia M. H. Mota
    Eloisa Bonfá
    Maria T. Terreri
    Pediatric Nephrology, 2023, 38 : 1843 - 1854
  • [35] Pharmacokinetics of Hydroxychloroquine in childhood-onset systemic lupus erythematosus
    Zahr, N.
    Gillion-Boyer, O.
    Bader-Meunier, B.
    Melki, I.
    Urien, U.
    Funck-Brentano, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 42 - 43
  • [36] Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus
    Brunner, HI
    Bishnoi, A
    Barron, AC
    Houk, LJ
    Ware, A
    Farhey, Y
    Mongey, AB
    Strife, CF
    Graham, TB
    Passo, MH
    LUPUS, 2006, 15 (04) : 198 - 206
  • [37] DNA Immunoadsorptionfor childhood-onset systemic lupus erythematosus
    Tang, Xuemei
    Zou, Zongyi
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1348 - 1348
  • [38] Obesity and Cytokines in Childhood-Onset Systemic Lupus Erythematosus
    Sinicato, Nailu Angelica
    Postal, Mariana
    Peres, Fernando Augusto
    Pelicari, Karina de Oliveira
    Marini, Roberto
    dos Santos, Allan de Oliveira
    Ramos, Celso Dario
    Appenzeller, Simone
    JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014
  • [39] Childhood-Onset Systemic Lupus Erythematosus: A Review and Update
    Harry, Onengiya
    Yasin, Shima
    Brunner, Hermine
    JOURNAL OF PEDIATRICS, 2018, 196 : 22 - +
  • [40] Abdominal manifestations in childhood-onset systemic lupus erythematosus
    Richer, O.
    Ulinski, T.
    Lemelle, I.
    Ranchin, B.
    Loirat, C.
    Piette, J. C.
    Pillet, P.
    Quartier, P.
    Salomon, R.
    Bader-Meunier, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) : 174 - 178